🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Graft-Versus-Host › Massachusetts › Boston

Qorannoo klinikaalii Dhukkubaa Graft-Versus-Host Boston, MA keessatti

Qorannoo 10 Dhukkubaa Graft-Versus-Host f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Namoota walitti qabaa jira
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06910969

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT06991361

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Namoota walitti qabaa jiraSadarkaa 2
  • Massachusetts General Hospital, Boston
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT04710576

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06615050

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Namoota walitti qabaa jiraSadarkaa 2
  • Boston Children's Hospital, Boston
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT04380740

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

Namoota walitti qabaa jira
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Bit-2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT06619561

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Dana Farber, Boston
36 Months · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT05866302

IS-free Treg HaploHCT

Namoota walitti qabaa jiraSadarkaa 1
  • Dana Farber Cancer Institute, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT04678401

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

Qorannoo Dhukkubaa Graft-Versus-Host magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.